KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 3 filers reported holding KRYSTAL BIOTECH INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $841,000 | +359.6% | 7,249 | +361.1% | 0.00% | – |
| Q2 2023 | $183,000 | +76.0% | 1,572 | +21.3% | 0.00% | – |
| Q1 2023 | $104,000 | -57.2% | 1,296 | -57.6% | 0.00% | – |
| Q4 2022 | $243,000 | +737.9% | 3,058 | +631.6% | 0.00% | – |
| Q3 2022 | $29,000 | +52.6% | 418 | +44.6% | 0.00% | – |
| Q2 2022 | $19,000 | -81.4% | 289 | -81.1% | 0.00% | – |
| Q1 2022 | $102,000 | -59.0% | 1,532 | -57.1% | 0.00% | – |
| Q4 2021 | $249,000 | +1085.7% | 3,568 | +798.7% | 0.00% | – |
| Q3 2021 | $21,000 | +250.0% | 397 | +341.1% | 0.00% | – |
| Q2 2021 | $6,000 | -92.9% | 90 | -91.8% | 0.00% | – |
| Q1 2021 | $85,000 | +372.2% | 1,098 | +269.7% | 0.00% | – |
| Q4 2020 | $18,000 | +350.0% | 297 | +301.4% | 0.00% | – |
| Q3 2020 | $4,000 | +33.3% | 74 | -14.0% | 0.00% | – |
| Q2 2020 | $3,000 | +50.0% | 86 | +59.3% | 0.00% | – |
| Q1 2020 | $2,000 | – | 54 | +390.9% | 0.00% | – |
| Q3 2018 | $0 | – | 11 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 1,896,645 | $150,252,217 | 6.15% |
| S Squared Technology, LLC | 108,215 | $8,572,792 | 5.80% |
| Frazier Life Sciences Management, L.P. | 999,737 | $79,199,165 | 4.92% |
| First Light Asset Management, LLC | 473,691 | $37,525,801 | 3.48% |
| Ikarian Capital, LLC | 165,900 | $13,142,598 | 3.17% |
| Soleus Capital Management, L.P. | 188,217 | $14,910,551 | 2.14% |
| Integral Health Asset Management, LLC | 115,000 | $9,110,300 | 1.91% |
| Nicholas Investment Partners, LP | 267,089 | $21,158,791 | 1.85% |
| Artal Group S.A. | 400,000 | $31,688 | 1.77% |
| Avoro Capital Advisors LLC | 1,410,000 | $111,700,200 | 1.67% |